Johnson & Johnson (JNJ) drops 136-year old logo and renames Janssen

New Brunswick, New Jersey–based Johnson & Johnson (NYSE: JNJ) has replaced its 136-year-old logo — based on the signature of co-founder James Wood Johnson — with a “more modern logo and brighter red, keeping the iconic ampersand,” J&J CEO Joaquin Duato said today in a post on LinkedIn. The change is meant to call attention to J&J’s focus on innovative medicine and medtech, he said.

The Janssen Pharmaceutical Cos. of Johnson & Johnson, meanwhile, is from now on going as Johnson & Johnson Innovative Medicine, “leading where medicine is going by developing breakthrough treatments, discovering new pathways and modalities, and expanding access so patients receive optimal care,” Duato said.

Sanofi launches new corporate brand and logo

 A little over a year ago, Pfizer changed its logo and corporate websites and today Sanofi is making the same move.

 

new (L), old (R)

The French Big Pharma's rebrand centers on a clean, lower case new logo with two purple dots at the start and end of its name.

The two purple dots “embody the scientific journey between a starting point and a finish line—the eureka moment where innovative solutions are unlocked to impact people’s lives,” Sanofi said in a statement.